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Abstract
Background: The relationship between fibrinogen concentration and traumatic death has been poorly explored
after severe trauma. Existing studies analysed this relationship in unselected trauma population, often considering
fibrinogen concentration as a categorical variable. The aim of our study was to model the relationship between
fibrinogen concentration and in-hospital mortality in severe trauma patients requiring massive transfusion using
fibrinogen on admission as a continuous variable.
Methods: We designed a retrospective observational study based on prospectively collected data from 2009 to
2015 in seven French level-I trauma centres. All consecutive patients requiring a transfusion of at least 10 packed
red blood cells (RBC) within 24 h were included. To assess the relationship between in-hospital death and fibrinogen
concentration on admission, we performed generalized linear and additive models with death as a dependent variable.
We also assessed the relationship between fibrinogen concentration below 1.5 g.L− 1 and potential predictors.
Results: Within the study period, 366 patients were included. A non-linear relationship was found between fibrinogen
concentration and death. Graphical modelling of this relationship depicted a negative association between fibrinogen
levels and death below a fibrinogen concentration of 1.5 g.L− 1. Predictors of low fibrinogen concentration (< 1.5 g.L− 1)
were systolic blood pressure, Glasgow coma scale and haemoglobin concentration on admission.
Conclusions: A complex and robust approach for modelling the relationship between fibrinogen and mortality
revealed a critical fibrinogen threshold of 1.5 g.L− 1 for severe trauma patients requiring massive transfusion. This trigger
may guide the administration of procoagulant therapies in this context.
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Introduction
Fibrinogen is a glycoprotein involved in the final process
of the coagulation cascade. This protein is the precursor
of fibrin that binds with platelets for clot formation [1].
Early decrease in fibrinogen concentration was found in
patients with on-going bleeding after severe trauma
suggesting a critical role for this coagulation factor in
such setting [2, 3]. Other authors demonstrated a poten-
tial relationship between fibrinogen concentration and
mortality in large unselected trauma population [4–6].
Based on this evidence, European guidelines recommend
maintaining fibrinogen level between 1.5 and 2 g.L− 1 [7].
However, there is still uncertainty regarding the relation-
ship between fibrinogen concentration and death during
the management of severe trauma patients with active
bleeding since different critical concentrations for fi-
brinogen have been reported between 1 and 2 g.L− 1
using different statistical approaches [4, 5, 8].
Apart from beneficial effects, aggressive correction of fi-
brinogen level can also induce a pro-thrombotic state with
potential thrombo-embolic events. Since post-traumatic
coagulopathy is characterized by a rapid shift from an
anti-thrombotic to a pro-thrombotic state [9], over-cor-
rection of fibrinogen concentration may promote delayed
severe side-effects in intensive care unit. Accordingly,
Wafaisade et al. reported a trend towards an increase in
thrombo-embolic events in patients receiving fibrinogen
therapy as compared to patients without fibrinogen ad-
ministration [10]. Taken together, these data indicate a
need for an accurate selection of patients requiring fi-
brinogen correction on admission based on a robust
threshold [11]. The relevancy of such threshold depends
on whether patients had massive haemorrhage or not
since fibrinogen concentration in patients without
significant bleeding is not relevant. As a result, the descrip-
tion of the relationship between fibrinogen concentration
on admission and death in a selected trauma population re-
quiring massive transfusion would help determining the
threshold to trigger the administration of procoagulant
therapies on admission. We, thus, designed a retrospective
study based on existing regional registries to model the re-
lationship between fibrinogen concentration and death in
patients who received a massive transfusion within the first
24 h. Our hypothesis is that fibrinogen concentration has a
non-linear relationship with in-hospital death in these pa-
tients, allowing the determination of the fibrinogen thresh-
old for increased risk of death.
Patients and methods
Study design and selection criteria
We designed a retrospective observational study based on
prospectively collected data from 2009 to 2015 by trauma
registries in seven French Level I trauma centres (Grenoble
Alps trauma centre, Annecy, Montpellier, Nimes, Marseille
(Hôpital Nord), Lyon-Sud and Lyon-Edouard Herriot
hospital). We included consecutive trauma patients who re-
ceived a massive transfusion defined by a transfusion of at
least 10 packed red blood cells (RBC) within the first 24 h
following the admission. Exclusion criteria were patients
under 15-year-old. The design of the study received ethical
approval by the French Society of Anaesthesiology and In-
tensive care (IRB number: CERAR 00010254–2017-052).
According to the French law No. 2012–300 (Decree No.
2016–1537), non-opposition of surviving patients was ob-
tained by an information letter, and the declaration was
made to the French Data Protection Authority.
Data collection
For each patient, we collected demographic data: age,
gender, type of injury, Injury Severity Score (ISS), Mech-
anism, Glasgow, Age and systolic arterial blood Pressure
(MGAP) score, transfusion requirement with RBC, Fresh
Frozen Plasma (FFP) and Platelet (PLT), and the type of
haemostatic treatment. Vital parameters including
systolic arterial blood pressure (SBP), heart rate, pulse
oximetry and Glasgow coma scale (GCS) were also re-
ported on admission. Morbidity and mortality assess-
ment consisted of death at 28-day, length of stay in
intensive care unit (ICU) and length of stay in hospital.
We also collected biologic data on admission: fibrinogen
concentration, prothrombin time, haemoglobin, platelet
count and lactate concentration.
Outcome and exposure
The primary endpoint was in-hospital death in order to
model the relationship between fibrinogen concentration
and death.
Secondary endpoint was low fibrinogen concentration
at hospital admission (< 1.5 g.L− 1) in order to explore
the relationship between low fibrinogen concentration
and potential predictors on admission (systolic blood
pressure, heart rate, Glasgow coma scale, age, gender,
haemoglobin concentration).
Statistical analysis
Baseline patient characteristics were reported as medians
and interquartile range (IQR 25th–75th) or means and
standard deviation when appropriate for continuous var-
iables. Categorical variables were reported as frequency
and percentages.
To assess the relationship between death and fibrino-
gen concentration on hospital admission, we performed
a Generalized Linear Model (GLM) with death as a
dependent variable. We graphically assessed the depart-
ure from linearity and include quadratic and cubic terms
in the equation to perform a polynomial regression
model. We removed, one at a time, each polynomial
term for which there was no evidence for an association
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based on the P values (< 0.05) from the Wald test. Each
time, we performed a likelihood ratio test between
models to ensure that removal of the variable did not
affect the model based on the P value (> 0.05). As we ex-
pected a nonlinear relationship between death and fi-
brinogen concentration, we performed in addition a
Generalized Additive Model (GAM). GAM is a flexible
method with a smooth function based on cubic spline
[12]. It allows characterizing nonlinear relationship of
exposure on outcome. We graphically assessed the rela-
tionship between death and fibrinogen concentration on
admission by plotting the predicted risk of death on fi-
brinogen concentration. The threshold value for fibrino-
gen concentration corresponded to the lowest value of
predicted risk of death. We assessed the performance of
the GLM in term of discrimination using the area under
the curve (AUC), the sensibility and specificity of the
threshold value and in term of calibration using the
calibration-in-the-large and the calibration slope.
To assess the relationship between low fibrinogen
concentration and potential predictors, we used the
threshold value estimated previously. We selected all
variables available on hospital admission: age, gender,
penetrating or blunt injury, SBP, heart rate and GCS.
Haemoglobin concentration was also included in the
variable selection as routinely available at the bedside.
We performed a GLM with low fibrinogen concentra-
tion as dependent variable. We used the same method
as the previous model for modelling continuous vari-
ables using linear and polynomial terms. In addition,
we performed a LASSO method (Least absolute
Shrinkage and Selection Operator) for variable selec-
tion of the model [13].
We tested all plausible interaction in the different
models. We assessed overall performance of the different
models with the Brier score and the discrimination with
concordance (or C) statistic, the sensitivity and specifi-
city of the threshold value. The calibration was assessed
by the calibration-in-the-large and the calibration slope.
We also included in the different models a random ef-
fect on trauma centre to control for clustering by using
mixed-effects GLM and mixed-effects GAM.
Regarding missing data, outcome was missing for one
patient. Fibrinogen concentration on admission was
missing for 42 patients (11%). We assumed that missing
data were at random. We performed multiple imput-
ation by chained equation. We generated 20 datasets of
366 observations to fill in missing values for fibrinogen
concentration on admission, systolic blood pressure,
heart rate, Glasgow coma scale and haemoglobin on
admission.
Two-sided p-values lower than 0.05 were considered
statistically significant. All analyses were performed
using Stata version 14.0 (Stata Corporation, College
Station, TX, USA) and R software version 3.4.3 using
mgcv package (R Foundation).
Fig. 1 Flow chart of the study
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Results
Within the study period, 366 consecutive patients
received at least 10 RBCs during the first 24 h. We esti-
mated that approximately 11,550 severe trauma patients
(ISS > 15) were admitted in the seven trauma centres
within the same study period. Flow chart of included
patients is presented in Fig. 1. Main demographic char-
acteristics of the trauma population are presented in
Table 1. Fibrinogen concentration on admission was
missing for 42 patients (11%). Other predictors were
missing from 3% up to 9% (Table 1). We imputed 118
missing values out of 1830 values (6%) to analyse 363
patients. Blood products and haemostatic procedures are
reported in Table 2. The median fibrinogen concentra-
tion on admission was 1.1 g.L− 1 [0.6–1.7]. At Day 28,
174 patients (48%) did not survive. Median duration of
ICU stay was 6 [1–20] days and median duration of
hospital stay was 16 [1–37] days.
The relationship between death and fibrinogen concen-
tration showed a statistically significant non-linear associ-
ation in both model: polynomial regression GLM (Fig. 2a)
and GAM (Fig. 2b). Both model showed a strong negative
association. The lowest value of the predicted risk of death
was for a fibrinogen concentration of 1.5 g.L− 1 and 1.3 g.
L− 1, respectively for the GLM and GAM. C-statistic was
0.63; 95% CI (0.57–0.69). The sensitivity for a fibrinogen
concentration of 1.5 g.L− 1 was 98% and a specificity of
3%. The ratio of the predicted risk of death and observed
death was 1.06; 95%CI (0.95–1.17) showing an adequate
calibration. Calibration slope was 1.2; 95%CI (0.74–1.74)
showing not overfitting.
Two hundred twenty four patients (62%) had a fibrinogen
concentration lower than 1.5 g.L− 1 on admission. The Table
3 reports the association between low fibrinogen concentra-
tion and predictors at baseline (hospital admission). Three
Table 2 Blood products and haemostatic procedures
Blood products within the first 24 h Median [IQR]
Red Blood Cells (Unit) 14 [11–19]
Fresh Frozen Plasma (Unit) 12 [8–16]
Platelet (Unit) 2 [1–3]
Fibrinogen concentrate (gr) 4.5 [3–7.5]
Emergency procedures N (%)
Surgery for bleeding 206 (64)
Embolization 83 (26)
IQR Interquartile Range
Table 1 Characteristics of the 366 patients with a massive transfusion following severe trauma
Value Missing (%)
Age years, mean (sd) 42 (18) 0
Male, n (%) 241 (75) 0
Injury Severity Score, mean (sd) 41 (17) 0.3
MGAP score, mean (sd) 20 (6) –
Penetrating injury, n(%) 30 (9) 0
Mechanism of injury, n (%) 0
Road traffic accident 185 (57) –
Fall 57 (18) –
Others 42 (13) –
Vital parameters at admission
Heart rate (bpm), mean (sd) 102 (34) 3.4
Systolic blood pressure (mmHg), mean (sd) 88 (35) 2.7
Glasgow coma scale, n(%) 5.8
3–8 140 (46) –
9–12 24 (8) –
13–15 140 (46) –
Biologic parameters at admission, Median [IQR]
Fibrinogen concentration (g/l) 1.1 [0.6–1.7] 0
Prothrombin time (%) 40 [28–58] 1.2
Platelet count (g/l) 137 [91–196] 4.6
Haemoglobin (g/l) 91 [74–111] 3.4
Lactate (mmol/l) 5.7 [3.2–9.5] 24.1
Sd Standard deviation, ISS Injury Severity Score, MGAP Mechanism, Glasgow, Age, systolic blood Pressure, Bpm Beats per minute, IQR Interquartile range
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predictors were associated to low fibrinogen concentration
(Fig. 3). Systolic blood pressure, Haemoglobin and GCS
showed a linear negative association with fibrinogen <
1.5 g.L− 1. Heart rate, age, gender and mechanism of injury
were not associated to low fibrinogen concentration. Penal-
ized regression model with LASSO did not show any
difference in the coefficient (less than 5% of relative differ-
ence) and in the variable selection.
Discussion
In a cohort of consecutive trauma patients with active
bleeding requiring massive transfusion, we observed a
Fig. 2 Modelling risk of death according to fibrinogen concentration: a. Generalized linear model (GLM) and b. Generalized additive model
(GAM). Footnotes Fig. 2 (a) Mixed-Generalized Linear Model (GLM) with random effect on trauma center. Polynomial regression including
quadratic and cubic terms. P value for linear term = 0.002; N = 363; C-stat = 0.62, Brier = 0.23; Predicted risk of death lowest value for fibrinogen
concentration of 1.50 (b) Mixed-Generalized Additive Model (GAM) with random effect on trauma center and 6 equivalent degree of freedom (P
value = 0.008). N = 363; Predicted risk of death lowest value for fibrinogen concentration of 1.31
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non-linear association between fibrinogen concentration
on admission and death. A strong negative association
between these parameters was observed below the fi-
brinogen threshold of 1.5 g.L− 1. Predictors for fi-
brinogen concentration lower than 1.5 g.L− 1 on
admission were classic vital parameters on admission:
systolic blood pressure, Glasgow coma scale and
haemoglobin. Our work highlights the role of fibrino-
gen in critically-bleeding patients after severe trauma
and further confirms the increase in the risk of death
below a fibrinogen concentration of 1.5 g.L− 1 on
admission.
Low fibrinogen concentrations have been frequently
described on admission and during the initial
management of severe trauma patients [11]. More im-
portantly, subsequent decrease in fibrinogen concen-
tration has been associated with injury severity and
post-traumatic coagulopathy [14]. In our study, we
also evaluated the association between fibrinogen on
admission and death. Previously, Hagemo et al.
showed a nonlinear relationship between fibrinogen
concentration and death using a multicentre cohort
of 1133 unselected trauma patients [4]. The incidence
of low fibrinogen concentration in this study was low
since only 93 (8.2%) patients had a fibrinogen value
lower than 1.5 g.L− 1. This study also included
non-haemorrhagic patients and identified a higher
critical threshold of 2.3 g.L− 1. Inaba et al. also
Table 3 Predictors at hospital admission, multivariate analysis
using Generalized Linear Model (GLM)
OR (95%CI) P value
Heart rate 1.01 (1.00–1.02) 0.093
Systolic blood pressure 0.99 (0.98–1.00) 0.064
Glasgow coma scale 0.92 (0.88–0.97) 0.002
Haemoglobin level 0.98 (0.97–0.99) < 0.001
Age 0.99 (0.97–1.00) 0.118
Sex male 0.81 (0.35–1.84) 0.596
Penetrating injury 0.80 (0.30–1.79) 0.494
Mixed-Generalized Linear Model; N = 362, C-stat = 0.74 95%CI (0.69–0.80),
Brier score = 0.19
Fig. 3 Predictors of low fibrinogen concentration in the generalized linear model (GLM). Each graph represents the relationship between a
predictor (systolic blood pressure, heart rate, Glasgow coma scale and haemoglobin) and the odds of fibrinogen concentration < 1.5 g.L− 1.
Footnotes Fig. 3 Mixed-Generalized Linear Model with random effect on trauma center; N = 362, C-stat = 0.75 95%CI (0.69–0.81), Brier score = 0.19
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reported a statistical association between fibrinogen
concentration and death in a single-centre cohort of
260 trauma patients with massive transfusion [8]. In
this study, the authors stratified patients in three cat-
egories following their fibrinogen levels on admission.
As a result, fibrinogen was not considered as a con-
tinuous variable, which induced a considerable bias to
analyse the relationship between fibrinogen and mor-
tality. A critical threshold was identified at 1 g.L− 1 by
this study. More recently, using an Australian
state-wide registry with 4773 patients, initial fibrino-
gen levels sorted in three categories were also inde-
pendently associated with in-hospital death [5]. Using
a more robust and complex analysis for continuous
variables, we found a threshold of 1.5 g.L− 1 in pa-
tients requiring massive transfusion after severe
trauma. Strengths of the present study are i) the limi-
tation of misclassification and false estimate by a
non-categorical approach for fibrinogen levels and ii)
a homogenous population of severe bleeding patients.
We also used a prospective inception cohort starting
at hospital admission. Finally, this study was based on
data collected from seven trauma centres that allows
more generalizable results than a single-centre study.
Predictors for low fibrinogen concentration were
classic vital parameters on admission such as heart
rate, systolic arterial blood pressure, Glasgow coma
scale and haemoglobin. Recently a trauma score,
named FibAT, was created to predict a fibrinogen
level lower than 1.5 g.L− 1 [15]. Predictors were iden-
tified using a derivation cohort of 2124 patients and
consisted of age, heart rate, SBP, blood lactate and
haemoglobin. We further confirmed these predictors
except for age. Although baseline fibrinogen levels de-
pend on age [16], the pathophysiology of fibrinolysis
and the loss of coagulation factors are conversely
independent from age [17]. We thus believe that the
threshold for increased the risk of death is not differ-
ent between a young and an old trauma population.
Potential mechanisms responsible for low fibrinogen
concentration on admission might be the activation of
fibrinolysis (due to the severity of injury and/or
on-going tissue hypoperfusion) and the loss of coagu-
lation factors by active bleeding [1, 18, 19].
One important issue when managing trauma pa-
tients with active bleeding is the establishment of
threshold to trigger the administration of procoagu-
lant therapies [20, 21]. With the present study, we
suggest that a fibrinogen concentration of 1.5 g.L− 1 is
critical in patients requiring massive transfusion after
severe trauma. This finding could be seen as a target
to guide the administration of fibrinogen concentrate
during resuscitation. More importantly, this threshold
may help the design of future studies using fibrinogen
concentrates. Indeed, there is still uncertainty regard-
ing fibrinogen targets when designing future trials
assessing the correction of fibrinogen deficit in
post-traumatic coagulopathy [20]. Our study indicates
that a fibrinogen level of 1.5 g.L− 1 is probably the
target to be reached in the intervention group.
We acknowledge several limits of our study. We
conducted a retrospective analysis of prospectively col-
lected data and we did not perform a prospective trial
per se. As a consequence, there is no randomization
and we cannot account for potential unknown con-
founders. Finally, missing values are inherent to retro-
spective studies based on on-going registries. However,
missing values did not interest the main outcome
(death) since only one value was missing. Moreover, we
performed multiple imputations to manage missing
values for predictors. We assumed that missing values
were at random. If not, this could lead to bias toward
the null. In addition of a probably lack of power, this
could explain the weak association between systolic
blood pressure, heart rate and low fibrinogen
concentration.
Conclusion
Low fibrinogen concentration on admission was associ-
ated with an increase in the risk of death in severe
trauma patients requiring massive transfusion. The
threshold of 1.5 g.L− 1 was found for a negative relation-
ship between fibrinogen levels and in-hospital death.
Classic vital parameters were independent predictors of
low fibrinogen concentration on admission. Our study
also provides information regarding the design of future
potential trials about fibrinogen supplementation after
severe trauma, suggesting a threshold of 1.5 g.L− 1 for fi-
brinogen concentrate therapy and may also guide the ad-
ministration of procoagulant therapies.
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